NEWS

Concept “One health”

URODELIA is actively involved in the strategy of sharing information between human and veterinary medicine.

The One Health concept is a global strategy to develop interdisciplinary collaborations and communications in all aspects of health care for humans, animals and the environment. This synergy will advance health care in the 21st century and beyond :

  • accelerating the discovery of biomedical research,
  • improving the effectiveness of public health,
  • rapidly expanding the scientific knowledge base
  • by improving medical education and clinical care.

Missions

Recognizing that human health (including mental health through man-animal linkage), animal health and ecosystem health are inextricably linked, One Health seeks to promote, enhance and defend health and well-being Being of all species by strengthening cooperation and collaboration among physicians, veterinarians, other health and scientific professionals and by promoting the leadership and management forces to achieve these goals.

Vision:

One Health is dedicated to improving the lives of all species, human and animal, through the integration of human medicine, veterinary medicine and the environment.

Health must be achieved by:

  • Joint education efforts among human doctors, veterinary schools and schools of public health and the environment;
  • Joint communication efforts in newspapers, conferences and related health networks;
  • Joint efforts in clinical care through assessment, treatment and prevention of disease transmission between species;
  • Joint efforts to monitor and combat diseases among species in public health;
  • Joint efforts for a better understanding of the transmission of diseases between species through comparative research in medicine and the environment;
  • Joint efforts in the development and evaluation of new diagnostic methods, drugs and vaccines for the prevention and control of diseases across species and;
  • Joint efforts to inform and educate political leaders and the public sector through accurate media publications

http://www.onehealthinitiative.com/about.php

Example of collaboration and translational model:

Targeted Oncolytic Adenoviruses for Canine Osteosarcoma: A translational Model- August 5, 2014

Dr. Smith is the director of Auburn Research Research in Cancer, a professor in the Department of Pathology and Scientific Research at the Scott-Ritchey Research Center. His long-term research interests are gene therapy of hereditary muscular diseases such as Duchenne muscular dystrophy, cancer gene therapy and nucleic acid immunization.

https://mizzouadvantage.missouri.edu/news/targeted-oncolytic-adenoviruses-for-canine-osteosarcoma-a-translational-model/

ESVONC CONGRESS LYON, France, 20-22th April 2017

esvonc-logo

Urodelia will attend the annual congress of European veterinary oncologists in Lyon at the end of the month.

Dr Frayssinet will present results on Thursday 20 April at 16:12.

“Mechanism of action of an autovaccine against cancer cells associating autologous tumor proteins to hydroxylapatite micro/nanoparticles”

Dr. Bayol will attend the conference on Friday, April 21.

http://www.esvonc.com/Congress/program

To read the presentation, click on the link below:

treatment-of-two-dogs-with-mast-cell-tumors-using-autologous-immunotherapy

World Vaccine Congress, USA, 10-12 th April 2017

world-vaccine-congress-washington-2017

Urodelia is an invited speaker at the 17th Annual Veterinary Vaccine Congress in Washington, 10-12 april 2017

Urodelia’s presentation will be  about:

Developing a novel vaccine for therapeutic treatment of cancer in companion animals

–              Clinical data demonstrating the progress in adaptive immunotherapy for cancer in companion animals
–              Harnessing the ability of the immune system to eradicate cancer sharing on mechanism of action
–              Lessons learnt from developing an innovative and patented immunotherapy method to treat cancer in companion animals

Dr Patrick Frayssinet will present on day 2 in the veterinary section

http://www.terrapinn.com/conference/world-vaccine-congress-washington/Agenda-Day-2.stm